- •* Stochastic effects
- •* Gray ( Gy)
- •Basis of the Radiotherapy of the Cancer and not malignant disease
- •*Cachectic condition
- •*Squamous cells carcinoma
- •What is the indication for the radiotherapy
- •* Adenocarcinoma
- •What is the contra indication for the radiotherapy
- •*Radiotherapy is not indicated
- •* Gamma therapy
- •On the planning of radiotherapy for the patient, multiple specialists are participated:
- •All true answers in mark a
- •External beam radiotherapy( ebrt) Distant radiotherapy
- •*Gamma Ray
- •Gamma Ray
- •Gamma Ray
- •*Electrontherapy
- •*Palliative radiotherapy
- •Internal radiation therapy brachytherapy
- •Intracavitary radiotherapy
- •* Intracavitary radiotherapy
- •Intracavitary radiotherapy
- •Gamma Ray
- •Gamma ray
- •Radiologic diagnostic imaging physics for diagnostic radiology
- •*All above mentioned
- •All above mentioned
- •All above mentioned
- •*All above mentioned
- •Diagnostic ultrasound magnetic resonans imaging
- •*All above mentioned
Internal radiation therapy brachytherapy
What types of radiopharmaceuticals are using for the interstitial Gamma therapy?
*All mentioned
Open radiopharmaceuticals
Closed radiopharmaceuticals
What property of the radionuclide is using in the radioisotope imaging?
*High specificity for the organ
Good solubility
Short half-life
Which methods of radiotherapy belong to brachytherapy
* Intracavitary
United radiotherapy
Dynamic radiotherapy
What is source of Gamma – Ray :
*Co 60
P 32
Tl 204
Au 198
Application beta therapy is using for cancer treatment with superficial localization in the skin and mucosa with the deep infiltration of the surrounded tissue. What is the penetration ability for the beta source?
* 1-2 mm
2,5-3 mm
3,1-3,5 mm
What source of the radiation is using for the interstitial radiotherapy?
*Closed
X-Ray
What is the early radiation skin lesion?
*Bullous edema and early radiation ulceration
Erythema
Dry radioepidermitis
Wet radioepidermitis
Epillation in the field of irradiation
What is the source-skin distance for short focus X-Ray therapy?(RUM -7 machine)
* 7,5 cm
5 cm
15 cm
Which condition has no contra indication for the radioisotope treatment by I 131?
*Thyrotoxicosis
Pregnancy and lactation
Nodular goiter
Child and teenager
Cervix cancer II stage is treated by the chart:
* External Gamma therapy TFD is 40 -42Gy
Internal Gamma therapy TFD is 12,5Gy
External Gamma therapy TFD is 40 -42Gy
Internal Gamma therapy TFD is 10, 5Gy
External Gamma therapy TFD is 40 -42Gy
Internal Gamma therapy TFD is 13, 5Gy
Which radiopharmaceutical is using for interstitial beta therapy?
*Cyrconium phosphate
P -32
Ir 192
Co-60
Persistent radiotherapy can be done by the:
*Application radiotherapy
Short focus radiotherapy
Distant radiotherapy
What method of radiotherapy is using for hyperkeratosis treatment?
* Application beta therapy
Application Gamma therapy
Interstitial Alfa therapy
What source is using for intracavitary gamma therapy?
*All mentioned
Open sources
Closed sources
Application Gamma therapy with source of low activity is using for superficial tumors with underlying tissue infiltration treatment. What is the penetration ability for this source?
* 1,0-1,5 cm
0,5-0,9 cm
1,6-2,1 cm
2,1-2,5 cm
What type of the radiotherapy is using for corneal tumor treatment?
* Application beta therapy
Application Gamma therapy
Interstitial Gamma therapy
What diameter of the superficially located tumor can be treated with interstitial Gamma therapy?
*Not more than 5 cm
Not more than 2 cm
Not more than 7 cm
When the early radiation reaction will appear?
*Reaction which are appears in time of radiotherapy or in closed 3 month after radiotherapy
Reaction which are appears in time of radiotherapy or in 3 day till 3 weeks after complete of radiotherapy
Reaction which are appears in3 days till 3 month after radiotherapy
What is the limitation for the patients traveling, who is treating with interstitial radiotherapy?
*Patient’s traveling is limited by the word “active “room
Bed rest
No limitation
What is the beta source, usually using for contact radiotherapy
*Au 198
Co 60
Ir 192
What is the treatment of the patient with diagnosis: Thyrotoxicosis mid stage?
*2,5 -3,0 MBq I -131 per 1 g glandular tissue
3.0 -3,5 MBq I- 131 per 1 g glandular tissue
3,5-4.0 MBq I- 131 per 1 g glandular tissue
What is the treatment of the Cervix cancer II stage
